Health and Life Sciences news
A Purdue University–affiliated company using artificial intelligence to improve health care delivery has received a $500,000 investment from Purdue Research Foundation’s Foundry Investment Fund to help it advance medical technology.
Coronavirus 2019-nCoV is genetically similar to the SARS variant, which killed more than 750 people from an outbreak that began in 2002, says Purdue scientist Andrew Mesecar, the Walther Professor in Cancer Structural Biology and head of the Department of Biochemistry. On Jan. 17, Mesecar and colleagues at the Center for Structural Genomics of Infectious Disease received the genome of the COVID-19 coronavirus, and he and his team analyzed the genome on Saturday (Jan. 18). Mesecar found that the genome is almost identical to that of the SARS virus.
As the COVID-19 coronavirus outbreak causes worldwide concern, Purdue University scientists say control measures are an absolute necessity and that medical treatments for similar disease are on the horizon.
Manufacturing prescription drugs with distinct markings, colors, shapes or packaging isn’t enough to protect them from counterfeiting, U.S. Drug Enforcement Administration reports have shown.
A pair of Purdue University students who have personal connections to cancer will help carry on the legacy of Tyler Trent, a Purdue graduate and superfan who died from a rare type of bone cancer.
The body can recover from many things, but the damage caused by Parkinson’s disease isn’t one of them.
Deep learning, 3D technology to improve structure modeling for protein interactions, create better drugs
Proteins are often called the working molecules of the human body. A typical body has more than 20,000 different types of proteins, each of which are involved in many functions essential to human life.